TY  - GEN
AU  - Wang,Min
AU  - Chen,Ping
AU  - Jia,Yan
AU  - He,Na
AU  - Li,Daqi
AU  - Ji,Chunyan
AU  - Ma,Daoxin
TI  - Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma
SN  - 1949-2553
PY  - 2016///0524
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Basic Helix-Loop-Helix Transcription Factors
KW  - genetics
KW  - Biomarkers, Tumor
KW  - blood
KW  - CD4 Lymphocyte Count
KW  - Case-Control Studies
KW  - China
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Female
KW  - Humans
KW  - Interferon-gamma
KW  - Interleukin-17
KW  - Interleukins
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - Neoplasm Staging
KW  - Nuclear Receptor Subfamily 1, Group F, Member 3
KW  - Polymerase Chain Reaction
KW  - RNA, Messenger
KW  - metabolism
KW  - Receptors, Aryl Hydrocarbon
KW  - Remission Induction
KW  - T-Lymphocyte Subsets
KW  - drug effects
KW  - Th17 Cells
KW  - Treatment Outcome
KW  - Interleukin-22
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.18632/oncotarget.4641
ER  -